therapeutics
2 articles tagged with ‘therapeutics’
Peptide-Antibody Conjugation for Targeted Biologics
Peptide-antibody conjugation combines high-specificity antibodies with functional peptides to create advanced therapeutics and diagnostics. This process addresses limitations like poor tissue penetration and lack of multifunctionality in monoclonal antibodies. Services cover design, synthesis, conjugation, and characterization for biologics development.
Peptide PEGylation: Boosting Stability and Half-Life
Peptide PEGylation attaches polyethylene glycol chains to peptides, improving solubility, extending circulation half-life, reducing degradation, and lowering immunogenicity. This approach addresses key limitations like rapid enzymatic breakdown and short plasma half-life in peptide therapeutics. It supports research from discovery to preclinical stages with precise synthesis and analysis.